INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/11/2026
Back to search
Official data from USPTO
ENVARSUS XR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
64
Latest update
05/12/2026
Trademark type
Combined
Nice classes
5, 40, 42, 44
Filing date
10/16/2014
Registration date
10/27/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/11/2025
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
US
Examiner
REINHART, MEGHAN M
Current location
Historical data usage
Mark description
The mark consists of three curved horizontal bands above the wording "ENVARSUS XR".
Holders and representatives
Holders
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S
Representatives
Julia Anne Matheson Potomac Law Group, PLLC
Technical classification
Nice Classes
Class 5Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsimmunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systemspharmaceutical modified release systemscontrolled release systemscomprised of tabletsgranulespillssachetspowderscapsulesall of the above for use in the treatment of mental and physical disorderstraumas and emergenciesaddictionsagingallergyimmunologyburnsdiseases of the heart and blood vesselsdental and gum diseasesskin diseasesnutritional and dietary diseasesdiseases of the endocrinological system and pancreatic diseasesdiabetesepidemical diseasesdiseases and afflictions of the gastroenterological systemdiseases of the bloodinfectious diseasesneurological diseasesnephrological diseasesdiseases in the obstetrical and gynaecological fieldcancerophthalmological diseasesdiseases and afflictions affecting the bonesjointscartilage material and musclesdiseases and afflictions of the earnose and threatdiseases and afflictions in the psychiatric fieldpulmonological diseases and afflictionsrheumatismurological diseases and afflictions and generalized pain
Class 40
Treatment of materialsmillinggrindingmixingcompressingmelting of pharmaceuticalmedicinalbio technical and bacteriological substancespreparationsformulations and solutionsfor use in the pharmaceutical and medical industries
Class 42
Scientific and technological servicesclinical testing and technology transfer services as well as research and design in connection therewithwithin the medicalpharmaceuticalbio technical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries
Class 44
Medical services; medical and pharmaceutical assistance and consultationmedical and pharmaceutical information servicesproviding medical and scientific research information in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
64 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/11/2025
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
09/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2025
ES71
TEAS SECTION 71 RECEIVED
05/30/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/08/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
10/28/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/17/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/21/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/21/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/21/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/21/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/21/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/25/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/25/2022
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
05/25/2022
REIN
REINSTATED
05/25/2022
NC71
NOTICE OF CANCELLATION SEC. 71 E-MAILED
05/24/2022
C71T
CANCELLED SECTION 71
05/23/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/17/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/28/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/28/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/28/2022
PUM1
OFFICE ACTION ISSUED POU1
11/22/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/17/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
10/26/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
09/18/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/21/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/27/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2020
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
09/21/2018
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
08/03/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/18/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/15/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/15/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/19/2016
FIMP
FINAL DISPOSITION PROCESSED
05/19/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/27/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
10/27/2015
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
09/01/2015
GPNX
NOTIFICATION PROCESSED BY IB
08/21/2015
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
08/21/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2015
PUBO
PUBLISHED FOR OPPOSITION
08/11/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/05/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/05/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/22/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/08/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2015
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/26/2015
ALIE
ASSIGNED TO LIE
06/24/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/17/2015
RFNT
REFUSAL PROCESSED BY IB
06/13/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/26/2015
RFRR
REFUSAL PROCESSED BY MPU
05/26/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/24/2015
CNRT
NON-FINAL ACTION WRITTEN
05/23/2015
MAFR
APPLICATION FILING RECEIPT MAILED
05/19/2015
DOCK
ASSIGNED TO EXAMINER
05/16/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2015
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/15/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/14/2015
Continuous trademark protection
Get notified about every new filing that threatens ENVARSUS XR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.